Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relapse rates following leprosy multidrug therapy.

M Suite1

  • 1Hansen's Disease Control Unit, Ministry of Health, Port of Spain, Trinidad and Tobago.

The West Indian Medical Journal
|November 15, 2000
PubMed
Summary

Leprosy patients in Trinidad and Tobago showed low relapse rates after multidrug therapy. Multibacillary cases had a 0.65% relapse rate, and paucibacillary cases had 1.5%.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous human myiasis due to Dermatobia hominis.

The West Indian medical journal·2008
Same author

The epidemiology of psoriasis in a dermatology clinic in a general hospital in Port-of-Spain, Trinidad and Tobago, West Indies.

The West Indian medical journal·2007
Same author

A survey to determine the prevalence of leprosy in a community in east Trinidad.

Leprosy review·1994
Same author

Unilateral comedo nevus associated with ipsilateral congenital cataract.

International journal of dermatology·1994
Same author

Tinea capitis in Trinidad.

The Journal of tropical medicine and hygiene·1993
Same author

Cushing's syndrome from topical glucocorticoids.

The West Indian medical journal·1993

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Leprosy, a chronic infectious disease, requires effective treatment regimens.
  • Multidrug therapy (MDT) is the standard treatment for all forms of leprosy.
  • Monitoring treatment outcomes, including relapse rates, is crucial for disease control.

Purpose of the Study:

  • To determine the relapse rates among leprosy patients treated with MDT in Trinidad and Tobago.
  • To compare these relapse rates with established global benchmarks.

Main Methods:

  • Retrospective study design.
  • Analysis of patient records from January 1982 to December 1994.
  • Categorization of patients into multibacillary and paucibacillary groups.

Main Results:

  • Overall low relapse rates observed.
  • Multibacillary leprosy cases exhibited a relapse rate of 0.65%.
  • Paucibacillary leprosy cases exhibited a relapse rate of 1.5%.

Conclusions:

  • MDT is effective in preventing relapses in leprosy patients in Trinidad and Tobago.
  • Observed relapse rates are comparable to World Health Organization (WHO) estimates.
  • Sustained vigilance and monitoring are essential for leprosy elimination efforts.

Related Experiment Videos